Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1546-0096
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Severe COVID-19 in pediatric age: an update on the role of the anti-rheumatic agents ; volume:19 ; number:1 ; day:4 ; month:5 ; year:2021 ; pages:1-11 ; date:12.2021
Pediatric rheumatology ; 19, Heft 1 (4.5.2021), 1-11, 12.2021
- Creator
-
Costagliola, Giorgio
Spada, Erika
Consolini, Rita
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12969-021-00559-5
- URN
-
urn:nbn:de:101:1-2021090720261425733072
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
01.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Costagliola, Giorgio
- Spada, Erika
- Consolini, Rita
- SpringerLink (Online service)
Other Objects (12)
Variability in response to anti-rheumatic drugs
The Effect of Anti-rheumatic Drugs on the Skeleton
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serumy‐Glutamylcysteine Leve
Pediatric cardiology updates
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serum γ ‐Glutamylcysteine Level
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
Variability in response to anti-rheumatic drugs
The Effect of Anti-rheumatic Drugs on the Skeleton
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serumy‐Glutamylcysteine Leve
Pediatric cardiology updates
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serum γ ‐Glutamylcysteine Level
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy
Influence of patient characteristics on perceived risks and willingness to take a proposed anti-rheumatic drug
Variability in response to anti-rheumatic drugs
The Effect of Anti-rheumatic Drugs on the Skeleton
Utilizing biologic disease-modifying anti-rheumatic treatment sequences to subphenotype rheumatoid arthritis
Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs
Patient participation in decisions about disease modifying anti-rheumatic drugs: a cross-sectional survey
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serumy‐Glutamylcysteine Leve
Pediatric cardiology updates
Limited effect of anti-rheumatic treatment on 15-prostaglandin dehydrogenase in rheumatoid arthritis synovial tissue
ASPS Exhibits Anti‐Rheumatic Effects by Reprogramming Gut Microbiota and Increasing Serum γ ‐Glutamylcysteine Level
The effect of newer anti-rheumatic drugs on osteogenic cell proliferation: an in-vitro study
The sequence of disease-modifying anti-rheumatic drugs: pathways to and predictors of tocilizumab monotherapy